Design and synthesis of a NAD(P)H:quinone oxidoreductase 1-activatable photosensitiser for controlled photodynamic therapy

被引：8
|
作者：
Xue, Evelyn Y. [1 ]
Kang, Fangyuan [1 ]
Zhou, Yimin [1 ]
Ng, Dennis K. P. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China
来源：
CHEMICAL COMMUNICATIONS | 2023年 / 59卷 / 46期
关键词：
STRATEGY; NQO1;
D O I：
10.1039/d3cc00683b
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The utilisation of enzymes as stimuli can activate theranostic agents in a highly specific manner. We report herein a far-red-absorbing boron dipyrromethene-based photosensitiser that is responsive towards the cancer-associated human NAD(P)H:quinone oxidoreductase 1, enabling the controlled restoration of photodynamic activity for selective elimination of cancer cells.
引用
收藏
页码：7056 / 7059
页数：4
相关论文
共 50 条
  • [41] NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer
    Zhang, Kuojun
    Chen, Dong
    Ma, Kun
    Wu, Xiaoxing
    Hao, Haiping
    Jiang, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) : 6983 - 7003
  • [42] Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamides
    Ghorab, Mostafa M.
    Higgins, Maureen
    Alsaid, Mansour S.
    Arafa, Reem K.
    Shahat, Abdelaaty A.
    Dinkova-Kostova, Albena T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2014, 29 (06) : 840 - 845
  • [43] Association of NAD(P)H:Quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese
    Bian, Jian-Tao
    Zhao, Hua-Lu
    Zhang, Zhen-Xin
    Bi, Xiu-Hua
    Zhang, Jun-Wu
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2008, 34 (03) : 235 - 240
  • [44] Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:Quinone oxidoreductase 1
    Siegel, D
    Anwar, A
    Winski, SL
    Kepa, JK
    Zolman, KL
    Ross, D
    MOLECULAR PHARMACOLOGY, 2001, 59 (02) : 263 - 268
  • [45] NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase) in bioactivation
    Ross, D
    Siegel, D
    Dehn, DL
    Winski, SL
    DRUG METABOLISM REVIEWS, 2002, 34 : 20 - 20
  • [46] Presence and induction of the enzyme NAD(P)H: Quinone oxidoreductase 1 in the central nervous system
    Stringer, JL
    Gaikwad, A
    Gonzales, BN
    Long, DJ
    Marks, LM
    Jaiswal, AK
    JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 471 (03) : 289 - 297
  • [47] Induction of the NAD(P)H: quinone oxidoreductase 1 by ketoconazole and itraconazole: A mechanism of cancer chemoprotection
    Korashy, Hesham M.
    Brocks, Dion R.
    El-Kadi, Ayman O. S.
    CANCER LETTERS, 2007, 258 (01) : 135 - 143
  • [48] Regulation of MUC5AC expression by NAD(P)H:quinone oxidoreductase 1
    Zheng, Shuo
    Byrd, Angela S.
    Fischer, Bernard M.
    Grover, Amy R.
    Ghio, Andrew J.
    Voynow, Judith A.
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 42 (09) : 1398 - 1408
  • [49] NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells
    Siegel, D
    Ryder, J
    Ross, D
    TOXICOLOGY LETTERS, 2001, 125 (1-3) : 93 - 98
  • [50] Involvement of NAD(P)H:Quinone Oxidoreductase 1 and Superoxide Dismutase Polymorphisms in Ulcerative Colitis
    Kosaka, Toshihito
    Yoshino, Junji
    Inui, Kazuo
    Wakabayashi, Takao
    Kobayashi, Takashi
    Watanabe, Shinya
    Hayashi, Shigekazu
    Hirokawa, Yoshifumi
    Shiraishi, Taizo
    Yamamoto, Takayuki
    Tsuji, Mayumi
    Katoh, Takahiko
    Watanabe, Masatoshi
    DNA AND CELL BIOLOGY, 2009, 28 (12) : 625 - 631
12345